Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial

P. Patel, Stephen J. Brett, David O’Callaghan, Aisha Anjum, Mary Cross, Jane Warwick, Anthony Gordon